International Journal of Hematology

DOI: 10.1007/s12185-017-2231-3 Pages: 196-205

Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8

1. Chiang Mai University, Department of Biochemistry, Faculty of Medicine

2. King’s College London, Division of Diabetes and Nutritional Sciences, School of Medicine

3. National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Thailand Science Park

4. Mahidol University, Thalassemia Research Center, Institute of Molecular Biosciences

Correspondence to:
Somdet Srichairatanakool



Atonal homolog 8 (ATOH8) is defined as a positive regulator of hepcidin transcription, which links erythropoietic activity with iron-sensing molecules. In the present study, we investigated the association between hepcidin and ATOH8 expression in β-thalassemia. We found that inhibition of hepcidin expression in β-thalassemia is correlated with reduced ATOH8 expression. Hepatic hepcidin 1 (Hamp1) and Atoh8 mRNA expression were down-regulated in β-thalassemic mice. Hepcidin (HAMP) and ATOH8 mRNA expression were consistently suppressed in Huh7 cells cultured in medium supplemented with β-thalassemia patient serum. The Huh7 cells, which were transfected with ATOH8-FLAG expression plasmid and cultured in the supplemented medium, exhibited increased levels of ATOH8 mRNA, ATOH8-FLAG protein, pSMAD1,5,8, and HAMP mRNA. Interestingly, over-expression of ATOH8 reversed the effects of hepcidin suppression induced by the β-thalassemia patient sera. In conclusion, hepcidin suppression in β-thalassemia is associated with the down-regulation of ATOH8 in response to anemia. We, therefore, suggest that ATOH8 is an important transcriptional regulator of hepcidin in β-thalassemia.

To access the full text, please Sign in

If you have institutional access, please click here

Share the Knowledge